|
|
||||||||
Papers In Press, published online ahead of print April 27, 2008
Clinical and Administrative Pharmacy, University of Iowa, Iowa City, IA 52242
Corresponding Author: mahfoud-assem{at}uiowa.edu
The nuclear hormone receptor Constitutive Androstane Receptor (CAR, NR1I3) regulates detoxification of xenobiotics and endogenous molecules, and has been shown to be involved in hepatic bile acids and cholesterol metabolism. The goal of this study was to address potential effects of CAR on the metabolism of high density lipoprotein (HDL) particles, key components in the reverse transport of cholesterol to the liver. Wild type (WT) mice, transgenic mice expressing human apolipoprotein A-I (HuAITg) and CAR-deficient (CAR-/-) mice were treated with the specific CAR agonist 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP). CAR activation decreased HDL cholesterol and plasma apoA-I levels in both WT and HuAITg mice, but not CAR-/- mice. Both mouse apolipoprotein A-I and human apolipoprotein A-I were decreased by more than 40 % after TCPOBOP treatment, and kinetic studies revealed that production rate of HDL is reduced in TCPOBOP-treated, wild-type mice. In transient transfections, TCPOBOP-activated CAR decreased the activity of the human apoA-I promoter. Although loss of CAR function did not alter HDL levels in normal chow fed mice, HDL cholesterol, apoA-I concentration, and apoA-I mRNA levels were increased in CAR-/- mice relative to WT mice when both were fed a high fat diet. We conclude that CAR activation in mice induces a pronounced decrease in circulating levels of plasma HDL at least in part through down-regulation of apolipoprotein A-I gene expression.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |